( Toronto:TTH,NASDAQ-NMS:TTHI )

News from transition therapeutics inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Jun 03, 2016, 06:01 ET Transition Therapeutics Receives Notification From NASDAQ

TORONTO, June 3, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced...


May 11, 2016, 16:01 ET Transition Therapeutics Announces Third Quarter Fiscal 2016 Financial Results

TORONTO, May 11, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a...


May 09, 2016, 16:01 ET Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2016 Financial Results on Wednesday, May 11th, at 4:30 P.M. EST

TORONTO, May 9, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) will hold a...


Apr 25, 2016, 16:01 ET Transition Therapeutics Announces Dosing of First Patient in Phase 2 Study of Drug Candidate TT701

TORONTO, April 25, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced the...


Apr 18, 2016, 06:01 ET Transition Therapeutics Provides Update on Type 2 Diabetes Drug Candidate TT401

TORONTO, April 18, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced that...


Mar 01, 2016, 16:30 ET Transition Therapeutics to Present at the 36th Annual Cowen Healthcare Conference

TORONTO, March 1, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced today...


Feb 09, 2016, 16:32 ET Transition Therapeutics Announces Second Quarter Fiscal 2016 Financial Results

TORONTO, Feb. 9, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a biopharmaceutical...


Feb 05, 2016, 13:01 ET Transition Therapeutics to Hold Conference Call on Second Quarter Fiscal 2016 Financial Results on Tuesday, February 9th, at 4:30 P.M. EST

TORONTO, Feb. 5, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) will hold a conference...


Feb 01, 2016, 06:01 ET Transition Therapeutics Announces Top Line Phase 2 Clinical Study Results of Diabetes Drug Candidate TT401

TORONTO, Feb. 1, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced the...


Jan 06, 2016, 06:01 ET Transition Therapeutics Announces Annual General Meeting Voting Results

TORONTO, Jan. 6, 2016 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announces that the...


Nov 19, 2015, 11:45 ET Transition Therapeutics to Host Investor Day November 23 in New York

Live Webcast Beginning at 12 PM Eastern Time TORONTO, Nov. 19, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company")...


Nov 02, 2015, 06:01 ET Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2016 Financial Results on Tuesday, November 10th, at 4:30 P.M. EST

TORONTO, Nov. 2, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) will hold a conference...


Sep 15, 2015, 16:01 ET Transition Therapeutics Announces Fiscal 2015 Financial Results

TORONTO, Sept. 15, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a...


Sep 14, 2015, 06:01 ET Transition Therapeutics to Hold Conference Call on Fiscal 2015 Financial Results on Tuesday, September 15th, at 4:30 P.M. EST

TORONTO, Sept. 14, 2015 /CNW/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) will hold a conference call...


Aug 10, 2015, 16:01 ET Transition Therapeutics to Present at the Canaccord Genuity 35th Annual Growth Conference

TORONTO, Aug. 10, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced today that...


Jun 24, 2015, 06:01 ET Transition Therapeutics Announces Results of Clinical Study of ELND005 in Agitation and Aggression in Patients with Alzheimer's Disease

TORONTO, June 24, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced that a Phase...


Jun 16, 2015, 06:01 ET Transition Therapeutics Appoints Carl Damiani as President

TORONTO, June 16, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) Chairman and Chief...


May 26, 2015, 06:01 ET Transition Therapeutics to Present at the Jefferies 2015 Healthcare Conference

TORONTO, May 26, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced today that Dr....


May 12, 2015, 16:01 ET Transition Therapeutics Announces Third Quarter Fiscal 2015 Financial Results

TORONTO, May 12, 2015 /PRNewswire/ -Transition Therapeutics Inc. ("Transition" or the "Company") (TSX: TTH; NASDAQ: TTHI), a biopharmaceutical...


May 07, 2015, 16:01 ET Transition Therapeutics to Hold Conference Call on Third Quarter Fiscal 2015 Financial Results on Tuesday, May 12th, at 4:30 P.M. EST

TORONTO, May 7, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) will hold a...


May 06, 2015, 06:01 ET Transition Therapeutics In-Licenses Phase 2 Drug Candidate from Lilly

TORONTO, May 6, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced its...


Mar 26, 2015, 06:01 ET Transition Therapeutics Announces Results from Phase 1 AME & Renal Clearance Clinical Studies of Neuropsychiatric Drug Candidate ELND005

TORONTO, March 26, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX:TTH) today announced...


Mar 02, 2015, 06:02 ET Transition Therapeutics Announces Enrolment Completion of ELND005 Phase 2 Clinical Study in Agitation and Aggression in Patients with Alzheimer's Disease

TORONTO, March 2, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced that its...


Feb 19, 2015, 13:30 ET Transition Therapeutics to Present at the Cowen and Company 35th Annual Healthcare Conference

TORONTO, Feb. 19, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) announced today that...


Feb 18, 2015, 16:01 ET Transition Therapeutics Inc. Announces Closing of Public Offering of US$23 Million of Common Shares

TORONTO, Feb. 18, 2015 /PRNewswire/ - Transition Therapeutics Inc. ("Transition" or the "Company") (NASDAQ: TTHI, TSX: TTH) today announced...